Advertisement
U.S. markets closed

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

NSE - NSE Real Time Price. Currency in INR
958.45-4.00 (-0.42%)
At close: 03:29PM IST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in INR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
270.20B240.97B241.20B190.72B131.21B119.78B
Enterprise Value
308.51B279.29B272.84B219.06B159.56B148.13B
Trailing P/E
N/AN/A94.8421.6514.8814.42
Forward P/E
14.90N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.111.791.811.541.060.99
Price/Book (mrq)
2.912.582.551.991.371.25
Enterprise Value/Revenue
2.4011.358.636.573.754.84
Enterprise Value/EBITDA
58.14-116.39196.9136.5170.2925.61

Trading Information

Stock Price History

Beta (5Y Monthly) 0.87
52-Week Change 3106.25%
S&P500 52-Week Change 327.86%
52 Week High 3974.00
52 Week Low 3445.75
50-Day Moving Average 3902.56
200-Day Moving Average 3813.60

Share Statistics

Avg Vol (3 month) 31.35M
Avg Vol (10 day) 3853.81k
Shares Outstanding 5282.19M
Implied Shares Outstanding 6282.35M
Float 8138.17M
% Held by Insiders 150.97%
% Held by Institutions 127.58%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.5
Forward Annual Dividend Yield 40.26%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 40.50
Payout Ratio 427.72%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 18, 2023
Last Split Factor 22:1
Last Split Date 3Sep 10, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -5.41%
Operating Margin (ttm)-14.19%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)131.58B
Revenue Per Share (ttm)466.24
Quarterly Revenue Growth (yoy)-27.60%
Gross Profit (ttm)N/A
EBITDA 15.79B
Net Income Avi to Common (ttm)-7.64B
Diluted EPS (ttm)-27.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.24B
Total Cash Per Share (mrq)39.83
Total Debt (mrq)51.82B
Total Debt/Equity (mrq)53.22%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)330.08

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A